'Biologic agents' presentation slideshows

APPROACH TO POLY-ARTHRITIS

APPROACH TO POLY-ARTHRITIS. DR CB NEL. Joints cartilage/ synovium. Arthritis. Inflammatory Rheumatoid arthritis Seronegative spondiloarthropaties Gout Septic. Degenerative Osteoartritis. Lower back pain. Diagnostic approach. Inflammatory vs. Noninflamatory Acute vs. Chronic

1.54k views • 69 slides

Cell Injury and the Pathogenesis of Human Disease (PATH 6266 )

755 views • 56 slides

Introduction, Review of Biomolecules

Introduction, Review of Biomolecules. Lecture 1, Medical Biochemistry. Lecture 1 Outline. Review some basic chemical nomenclature and concepts Review the structural and functional features of different biomolecules Discuss the human genome project and the future of molecular medicine .

472 views • 26 slides

Practice Points From RA Registries and Pragmatic Trials

282 views • 19 slides

PharmaPoint: Asthma - Global Drug Market Forecast

Big Market Research, PharmaPoint: Global Asthma Drug Market Size, Share, Strategies, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities. Big Market Research added a new research report "PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023". Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade. The largest unmet needs mainly reflect the high level of heterogeneity of the disease, the lack of patient compliance with the standard therapies, and the high cost of medications for asthma treatment. In addition, there is a lack of diagnostic tools to provide a reliable diagnosis of asthma in young children. Annualized asthma therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023. More info @ http://www.bigmarketresearch.com/pharmapoint-asthma-global-drug-forecast-and-analysis-to-2023-market

338 views • 13 slides

Figure 4 Effect of adalimumab on new erosions in patients with hand OA

117 views • 1 slides

Table 1 Possible molecular targets and corresponding biologic agents in SLE

Table 1 Possible molecular targets and corresponding biologic agents in SLE. Stohl, W. (2013) Future prospects in biologic therapy for systemic lupus erythematosus Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2013.136.

132 views • 1 slides